...
首页> 外文期刊>Breast cancer research and treatment. >Hereditary diffuse gastric cancer and lynch syndromes in a BRCA1/2 negative breast cancer patient
【24h】

Hereditary diffuse gastric cancer and lynch syndromes in a BRCA1/2 negative breast cancer patient

机译:BRCA1 / 2阴性乳腺癌患者的遗传性弥漫性胃癌和林奇综合征

获取原文
获取原文并翻译 | 示例

摘要

Genetic counseling and testing is recommended for women with a personal and/or family history of breast and other cancers (ovarian, pancreatic, male breast and others). Mutations in the BRCA1 and BRCA2 genes (BRCA1/2) are the most common causes of hereditary breast and ovarian cancer. Additional genetic counseling and testing with a multi-gene panel may be considered in breast cancer patients who tested negative for mutations in these two genes. In about 11% of BRCA1/2-negative patients, further genetic testing reveals pathogenic mutations in other high or moderate cancer risk genes. In 0.2% of cases, an individual may carry pathogenic mutations in more than one high penetrance gene (a double heterozygote). Finding one or more pathogenic mutations is important for cancer prevention in patients and/or their families.
机译:建议为乳腺癌和其他癌症(卵巢,胰腺,男性乳房等)的妇女推荐遗传咨询和测试。 BRCA1和BRCA2基因(BRCA1 / 2)中的突变是遗传性乳腺癌和卵巢癌的最常见原因。 额外的遗传咨询和使用多基因面板进行乳腺癌患者可以考虑在这两个基因中测试阴性的乳腺癌患者。 在约11%的BRCA1 / 2阴性患者中,进一步的遗传检测揭示了其他高或中度癌症风险基因的致病性突变。 在0.2%的病例中,个体可以在一个以上的高渗透基因(双杂合子)中携带病原突变。 寻找一个或多个致病性突变对于患者和/或其家庭的癌症预防是重要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号